MY
Myomo, Inc.
MYO · AMEX
$1.36 +1.12% (+$0.02)
1M +0.70%
Market Cap $52.9M
P/E Ratio -
Div. Yield -
ROE 142.02%
Bulios Fair Price
$1
26.2% downside
Current Price
$1.36
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MYO is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Weak
2/9Valuation
50 /100
Fair P/B 9.08x
P/S 1.22x
EV/EBITDA N/A
Growth
100 /100
Growing Book val. growth 21.49%
Rev. growth 38.05%
FCF growth N/A
Profitability
20 /100
Weak Net margin 33.53%
Op. margin 27.05%
FCF margin 20.42%
Quality
15 /100
Poor ROE 142.02%
ROA 41.05%
Asset turnover 1.22x
Debt
23 /100
High Current ratio 2.31x
Int. coverage -6.86x
Debt/Equity 3.44x
Stability
22 /100
Unstable Rev. volatility 25.69%
EPS volatility 113.36%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MYO
Online
Sector
Healthcare
Industry
Medical - Devices
CEO
Paul R. Gudonis
Employees
195
Headquarters
Burlington
Upcoming events
09 NOV
Earnings
Upcoming earnings report